Artificial Intelligence is no longer a futuristic concept—it’s already shaping healthcare delivery, diagnostics, and operations. But here’s the truth: adopting AI isn’t just a technology challenge, it’s a leadership challenge.

In this episode, Vikram Venkateswaran unpacks three key lessons from The AI-Savvy Leader by David De Cremer and explores what they mean for healthcare:

1️⃣ Why leaders must start with purpose, not technology.
2️⃣ How to adopt a humans-plus-AI mindset that empowers clinicians.
3️⃣ The importance of continuous learning and accountability to keep AI safe, effective, and trusted.

The stakes in healthcare are higher than anywhere else—patient lives and public trust. This episode offers a roadmap for leaders who want to move beyond hype and ensure AI truly serves patients, clinicians, and systems.

👉 If you’re a healthcare leader looking to make sense of AI and its real-world impact, this one’s for you.

In this episode, Dr Vikram Venkateswaran chats with Madan Sampat, VP of Supply Chain and Projects at HCG, who shares his journey across healthcare, finance, and leadership. We explore the realities of hospital operations, resilient supply chains, pricing, and capital markets — as well as his advice for the next generation of healthcare entrepreneurs.

Whether you’re an investor, entrepreneur, or healthcare professional, this episode is packed with insights that can shape your decisions in India’s evolving healthcare ecosystem.

In this episode of the Healthcare India Podcast, Dr Vikram Venkateswaran explores the evolving landscape of healthcare funding in 2025. While global deal volumes are declining, mega-deals and acquisitions—particularly in AI-enabled healthcare—are keeping funding values high.

Closer to home, India has emerged as a healthcare investment hotspot. Healthtech funding reached $828M in H1 2025, with private equity investments of nearly ₹4,900 crore across 33 deals in Q2 alone.

Key highlights from this episode include:

• The $775M Manipal–Sahyadri Hospitals acquisition ahead of Manipal’s IPO.

• PB Healthcare’s $218M seed round led by General Catalyst—an ambitious integration of care delivery and insurance.

• ADIA’s $200M investment into Meril Micro Life Sciences, bolstering India’s medical device exports.

• Advent International’s $175M investment in Felix Pharmaceuticals signals rising interest in animal health.

• Truemeds’ $90M Series C round to consolidate the e-pharmacy space.

Dr Vikram shares strategic insights on what these deals mean for healthcare founders, investors, and the future of Indian healthcare. The key message: capital is available, but it’s concentrated—only scalable models with strong ROI and patient acquisition clarity will thrive.

🎧 Tune in to understand where healthcare funding is headed and how it will shape the sector in the years to come.